Approvals/TGA/OMVOH mirikizumab 100 mg/mL + 200 mg/2 mL solution for injection autoinjector (pre-filled pen) composite pack (citrate-free formulation)

Approved

STANDARD

OMVOH mirikizumab 100 mg/mL + 200 mg/2 mL solution for injection autoinjector (pre-filled pen) composite pack (citrate-free formulation)

Eli Lilly Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Date: Jul 8, 2025
Approval ID: fcd8ed7a3c63a914
Company: Eli Lilly Australia Pty Ltd
Type: Standard

Approval Details

Approval Id: fcd8ed7a3c63a914
Product Name: OMVOH mirikizumab 100 mg/mL + 200 mg/2 mL solution for injection autoinjector (pre-filled pen) composite pack (citrate-free formulation)
Artg Id: 461105
Artg Name: OMVOH mirikizumab 100 mg/mL + 200 mg/2 mL solution for injection autoinjector (pre-filled pen) composite pack (citrate-free formulation)
Sponsor: Eli Lilly Australia Pty Ltd
Company Detail Path: /organization/eli-lilly-australia-pty-ltd
Artg Date: 2025-07-04
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Active Ingredients

Approved

Quick Info

Agency

TGA

Country

🇦🇺

Approval Date

Jul 8, 2025

Approval ID

fcd8ed7a3c63a914

Type

Standard

Back to TGA Approvals